Free Trial
NASDAQ:NAGE

Niagen Bioscience (NAGE) Stock Price, News & Analysis

Niagen Bioscience logo
$12.71 +0.13 (+1.03%)
As of 07/3/2025 01:00 PM Eastern

About Niagen Bioscience Stock (NASDAQ:NAGE)

Key Stats

Today's Range
$12.16
$12.74
50-Day Range
$7.56
$14.41
52-Week Range
$2.40
$14.69
Volume
727,210 shs
Average Volume
1.00 million shs
Market Capitalization
$1.00 billion
P/E Ratio
74.76
Dividend Yield
N/A
Price Target
$19.50
Consensus Rating
Buy

Company Overview

Niagen Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

NAGE MarketRank™: 

Niagen Bioscience scored higher than 27% of companies evaluated by MarketBeat, and ranked 803rd out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Niagen Bioscience has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Niagen Bioscience has only been the subject of 2 research reports in the past 90 days.

  • Read more about Niagen Bioscience's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Niagen Bioscience is 74.76, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.55.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Niagen Bioscience is 74.76, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.52.

  • Price to Book Value per Share Ratio

    Niagen Bioscience has a P/B Ratio of 21.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for NAGE.
  • Dividend Yield

    Niagen Bioscience does not currently pay a dividend.

  • Dividend Growth

    Niagen Bioscience does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for NAGE.
  • News Sentiment

    Niagen Bioscience has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Niagen Bioscience this week, compared to 5 articles on an average week.
  • Search Interest

    Only 7 people have searched for NAGE on MarketBeat in the last 30 days. This is a decrease of -61% compared to the previous 30 days.
  • MarketBeat Follows

    10 people have added Niagen Bioscience to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Niagen Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.39% of the stock of Niagen Bioscience is held by insiders.

  • Percentage Held by Institutions

    Only 15.41% of the stock of Niagen Bioscience is held by institutions.

  • Read more about Niagen Bioscience's insider trading history.
Receive NAGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Niagen Bioscience and its competitors with MarketBeat's FREE daily newsletter.

NAGE Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
See More Headlines

NAGE Stock Analysis - Frequently Asked Questions

Niagen Bioscience's stock was trading at $5.48 on January 1st, 2025. Since then, NAGE stock has increased by 131.9% and is now trading at $12.71.

Shares of NAGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NAGE
Previous Symbol
NASDAQ:NAGE
Web
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$19.50
High Stock Price Target
$23.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+53.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
74.76
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$8.55 million
Pretax Margin
13.51%

Debt

Sales & Book Value

Annual Sales
$99.60 million
Cash Flow
$0.06 per share
Price / Cash Flow
212.68
Book Value
$0.60 per share
Price / Book
21.18

Miscellaneous

Free Float
71,373,000
Market Cap
$1.00 billion
Optionable
N/A
Beta
2.14
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:NAGE) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners